Handugan, Rosalina A.

HRN: 11-32-26  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2022
CIPROFLOXACIN 500MG (TAB)
08/17/2022
08/21/2022
PO
500mg
BID
UTI (Resolving)
Waiting Final Action 
08/17/2022
CEFTRIAXONE 1G (VIAL)
08/17/2022
08/24/2022
IV
2g
Q24H
Complicated UTI
Waiting Final Action 
08/19/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/19/2022
08/19/2022
IV
4.5gm
Now
UTI
Waiting Final Action 
08/19/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/19/2022
08/25/2022
IV
2.25gm
Q8
Urinalysis UTI
Waiting Final Action 
09/13/2022
AZITHROMYCIN 500MG TABLET (TAB)
09/13/2022
09/17/2022
PO
500 Mg
Od
CAP-MR
Waiting Final Action 
09/13/2022
CEFTRIAXONE 1G (VIAL)
09/13/2022
09/19/2022
IV
2g
OD
CAP-MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: